Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. PT Kimia Farma Persero Tbk's Total Liabilities for the quarter that ended in Jun. 2026 was Rp12,134,212 Mil. PT Kimia Farma Persero Tbk's Total Assets for the quarter that ended in Jun. 2026 was Rp14,698,071 Mil.
Therefore, PT Kimia Farma Persero Tbk's Liabilities-to-Assets Ratio for the quarter that ended in Jun. 2026 was 0.83.
PT Kimia Farma Persero Tbk (ISX:KAEF) Liabilities-to-Assets Explanation
Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.
PT Kimia Farma Persero Tbk Liabilities-to-Assets Related Terms
PT Kimia Farma Persero Tbk Liabilities-to-Assets Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Persero Tbk Liabilities-to-Assets Chart
ISX:KAEF vs MCK, COR, CAH: Liabilities-to-Assets Comparison
For the Medical Distribution subindustry, PT Kimia Farma Persero Tbk's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Persero Tbk Liabilities-to-Assets vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Persero Tbk's Liabilities-to-Assets distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Persero Tbk's Liabilities-to-Assets falls into.
PT Kimia Farma Persero Tbk Liabilities-to-Assets Calculation
Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.
PT Kimia Farma Persero Tbk's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Persero Tbk (ISX:KAEF) has a Liabilities-to-Assets of 0.83 as of Jun. 2026. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on PT Kimia Farma Persero Tbk and its competitors.
Is PT Kimia Farma Persero Tbk's Liabilities-to-Assets too high?
PT Kimia Farma Persero Tbk's current Liabilities-to-Assets is 0.83. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's Liabilities-to-Assets compare to MCK and COR?
PT Kimia Farma Persero Tbk's Liabilities-to-Assets of 0.83 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Liabilities-to-Assets for a Medical Distribution company?
A good Liabilities-to-Assets depends on the Medical Distribution industry context. However, Liabilities-to-Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Liabilities-to-Assets mean?
A high Liabilities-to-Assets can signal that a stock is expensive relative to its fundamentals. Liabilities-to-Assets equals total liabilities divided by total assets. It measures financial leverage. View historical data on PT Kimia Farma Persero Tbk and its competitors. PT Kimia Farma Persero Tbk's current Liabilities-to-Assets is 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp574.38, compared to a current price of Rp434.00 — trading 24.4% below its estimated fair value. The current Liabilities-to-Assets is 0.83. PT Kimia Farma Persero Tbk's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Liabilities-to-Assets calculated?
Liabilities-to-Assets is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current Liabilities-to-Assets is 0.83 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued.
The current stock price of Rp434.00 is trading 24.4% below its estimated GF Value™ of Rp574.38.
GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
Liabilities-to-Assets: 0.83
GF Value™: Rp574.38 vs. price of Rp434.00 (24.4% below fair value)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Persero Tbk is an Indonesian state-owned pharmaceutical and healthcare company. It operates through integrated segments covering manufacturing, distribution, retail pharmacy, and other healthcare services. The manufacturing arm produces prescription (ethical) medicines, generic drugs, over-the-counter and herbal products, and cosmetics, with brands including Alergine, Kimoxil, Loprezol, Enkasari, and Batugin. Its distribution business supplies pharmaceuticals and medical devices to hospitals, pharmacies, and other healthcare providers across Indonesia, while its retail network, operated largely under the Kimia Farma Apotek banner, serves consumers directly through pharmacies and clinics. The company also provides clinical laboratory and diagnostic services. Revenue is generated primarily through its retail pharmacy operations, supplemented by manufacturing sales and distribution services. Kimia Farma is listed on the Indonesia Stock Exchange and operates predominantly within the Indonesian market, with limited international activity.
53GF Score
Get the complete analysis for ISX:KAEF
Liabilities-to-Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
